Wendy A. Wolf

2.8k total citations · 1 hit paper
35 papers, 813 citations indexed

About

Wendy A. Wolf is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Wendy A. Wolf has authored 35 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Genetics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Wendy A. Wolf's work include Diabetes Management and Research (18 papers), Diabetes Treatment and Management (13 papers) and Diabetes and associated disorders (10 papers). Wendy A. Wolf is often cited by papers focused on Diabetes Management and Research (18 papers), Diabetes Treatment and Management (13 papers) and Diabetes and associated disorders (10 papers). Wendy A. Wolf collaborates with scholars based in United States, Philippines and Hungary. Wendy A. Wolf's co-authors include Rex L. Chisholm, Teng-Leong Chew, Patricia J. Gallagher, Fumio Matsumura, Joshua C. Denny, Maureen E. Smith, Gail P. Jarvik, Abel Kho, Jennifer A. Pacheco and David R. Crosslin and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Development.

In The Last Decade

Wendy A. Wolf

35 papers receiving 795 citations

Hit Papers

Severe Hypoglycemia and Impaired Awareness of Hypoglycemi... 2024 2026 2025 2024 10 20 30 40
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey
    2024 42 citations Jennifer L. Sherr, Lori M. Laffel et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendy A. Wolf United States 14 299 229 158 139 94 35 813
Anja Rudolph Germany 17 199 0.7× 360 1.6× 59 0.4× 112 0.8× 28 0.3× 28 1000
Jeffery L. Painter United States 10 394 1.3× 525 2.3× 38 0.2× 56 0.4× 29 0.3× 28 1.3k
Håvard Søiland Norway 20 250 0.8× 406 1.8× 89 0.6× 35 0.3× 52 0.6× 58 1.3k
Akira Endoh Japan 13 82 0.3× 238 1.0× 211 1.3× 79 0.6× 19 0.2× 37 710
Weixiong Lin China 16 124 0.4× 199 0.9× 163 1.0× 33 0.2× 39 0.4× 55 756
Lisa A. Bastarache United States 9 461 1.5× 309 1.3× 38 0.2× 53 0.4× 22 0.2× 11 954
R Thomas Lumbers United Kingdom 17 245 0.8× 481 2.1× 100 0.6× 54 0.4× 27 0.3× 30 1.3k
Mindy Clyne United States 17 526 1.8× 433 1.9× 33 0.2× 144 1.0× 11 0.1× 26 1.2k
Toomas Haller Estonia 9 253 0.8× 280 1.2× 48 0.3× 82 0.6× 15 0.2× 21 712
Dragi Anevski Sweden 9 447 1.5× 328 1.4× 332 2.1× 54 0.4× 29 0.3× 21 1.1k

Countries citing papers authored by Wendy A. Wolf

Since Specialization
Citations

This map shows the geographic impact of Wendy A. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy A. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy A. Wolf more than expected).

Fields of papers citing papers by Wendy A. Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy A. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy A. Wolf. The network helps show where Wendy A. Wolf may publish in the future.

Co-authorship network of co-authors of Wendy A. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy A. Wolf. A scholar is included among the top collaborators of Wendy A. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy A. Wolf. Wendy A. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kelly, Caitlin S., et al.. (2024). Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type 1 Diabetes: A Brief Report. Diabetes Therapy. 15(10). 2249–2261. 1 indexed citations
3.
Sherr, Jennifer L., Lori M. Laffel, Jingwen Liu, et al.. (2024). Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey. Diabetes Care. 47(6). 941–947. 42 indexed citations breakdown →
4.
Laffel, Lori M., Jennifer L. Sherr, Jingwen Liu, et al.. (2024). Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method. Diabetes Care. 48(2). 273–278. 2 indexed citations
5.
Nguyen, Huyen, et al.. (2023). Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes. Clinical Diabetes. 41(3). 399–410. 2 indexed citations
6.
Rioles, Nicole, Jingwen Liu, Wendy A. Wolf, et al.. (2023). Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician’s perspective on its implementation. BMJ Open Diabetes Research & Care. 11(4). e003394–e003394. 13 indexed citations
7.
Kelly, Caitlin S., et al.. (2023). 634-P: Autoantibody Screening Attitudes and Experiences in People Affected by Type 1 Diabetes. Diabetes. 72(Supplement_1). 1 indexed citations
8.
Dimsits, Jeannett, et al.. (2022). “It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes. Journal of Clinical & Translational Endocrinology. 30. 100310–100310. 1 indexed citations
9.
10.
Nguyen, Huyen, et al.. (2022). Emergency Glucagon: a Focused Review of Psychosocial Experiences of Rescue Drugs for Type 1 Diabetes. Current Diabetes Reports. 22(4). 189–197. 4 indexed citations
11.
Liu, Jingwen, et al.. (2021). 186-LB: T1D Exchange Registry: Current Insights on Participant Outcomes. Diabetes. 70(Supplement_1). 5 indexed citations
12.
13.
Overby, Casey Lynnette, John J. Connolly, Christopher G. Chute, et al.. (2016). Practical considerations for implementing genomic information resources. Applied Clinical Informatics. 7(3). 870–882. 22 indexed citations
14.
Jeff, Janina M., Loren L. Armstrong, Marylyn D. Ritchie, et al.. (2014). Admixture Mapping and Subsequent Fine-Mapping Suggests a Biologically Relevant and Novel Association on Chromosome 11 for Type 2 Diabetes in African Americans. PLoS ONE. 9(3). e86931–e86931. 12 indexed citations
15.
Brothers, Kyle B., John Lynch, Sharon Aufox, et al.. (2014). Practical Guidance on Informed Consent for Pediatric Participants in a Biorepository. Mayo Clinic Proceedings. 89(11). 1471–1480. 21 indexed citations
16.
Fusaro, Vincent A., Catherine A. Brownstein, Wendy A. Wolf, et al.. (2013). Development of a scalable pharmacogenomic clinical decision support service.. PubMed. 2013. 60–60. 6 indexed citations
17.
Fullerton, Stephanie M., Wendy A. Wolf, Kyle B. Brothers, et al.. (2012). Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genetics in Medicine. 14(4). 424–431. 77 indexed citations
18.
Kho, Abel, M. Geoffrey Hayes, Laura J. Rasmussen‐Torvik, et al.. (2011). Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. Journal of the American Medical Informatics Association. 19(2). 212–218. 216 indexed citations
19.
McGuire, Amy L., Melissa Basford, Lynn G. Dressler, et al.. (2011). Ethical and practical challenges of sharing data from genome-wide association studies: The eMERGE Consortium experience. Genome Research. 21(7). 1001–1007. 55 indexed citations
20.
Kengyel, András, Wendy A. Wolf, Rex L. Chisholm, & James R. Sellers. (2010). Nonmuscle myosin IIA with a GFP fused to the N-terminus of the regulatory light chain is regulated normally. Journal of Muscle Research and Cell Motility. 31(3). 163–170. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Rudolph Breakdown of academic impact, for papers by Jeffery L. Painter Breakdown of academic impact, for papers by Håvard Søiland Breakdown of academic impact, for papers by Akira Endoh Breakdown of academic impact, for papers by Weixiong Lin Breakdown of academic impact, for papers by Lisa A. Bastarache Breakdown of academic impact, for papers by R Thomas Lumbers Breakdown of academic impact, for papers by Mindy Clyne Breakdown of academic impact, for papers by Toomas Haller Breakdown of academic impact, for papers by Dragi Anevski
Rankless by CCL
2026